Related Experiment Videos
Update on recognition and management of patients with acquired or inherited hypercoagulability
1Hematology/Medical Oncology Section, Washington Hospital Center, Washington, D.C. 20010, USA.
Comprehensive Therapy
|July 21, 1998
Abstract:
As many as 20% of individuals who develop venous thromboembolism (VTE) in an outpatient setting may have a mutation in factor V (factor V Leiden) or the prothrombin gene. Through testing for the inherited and acquired conditions for VTE, the clinician can develop strategies to prevent recurrences.